Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Insulinoma × 68Ga-NOTA-exendin-4 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Trastuzumab 2 Everolimus 2 veliparib 1 vatalanib 1 tipifarnib 1 pentetreotide 1 fluorodopa F 18 1 cixutumumab 1 Temozolomide 1 Salts 1 Oxaliplatin 1 Octreotide 1 Leucovorin 1 Interleukin-12 Subunit p35 1 Interleukin-12 1 High-Energy Shock Waves 1 Floxuridine 1 Capecitabine 1 Acetates 1 90Y-octreotide, DOTA-Tyr(3)- 1 68Ga-NOTA-exendin-4 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04979611 2023-09-21

The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

First Affiliated Hospital of Fujian Medical University

Phase 1 Unknown

Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡